Oxybutynin and Specific gravity urine decreased - a phase IV clinical study of FDA data

Summary:

Specific gravity urine decreased is reported as a side effect among people who take Oxybutynin (oxybutynin), especially for people who are female, 50-59 old, have been taking the drug for 1 - 6 months also take Gravol, and have Relapsing-remitting multiple sclerosis.

The phase IV clinical study analyzes which people have Specific gravity urine decreased when taking Oxybutynin. It is created by eHealthMe based on reports of 22,833 people who have side effects when taking Oxybutynin from the FDA, and is updated regularly.

What is Oxybutynin?

Oxybutynin has active ingredients of oxybutynin. It is often used in urge incontinence. eHealthMe is studying from 23,143 Oxybutynin users. Check the latest studies of Oxybutynin.

What is Specific gravity urine decreased?

Specific gravity urine decreased is found to be associated with 66 drugs and 78 conditions by eHealthMe. Check the latest studies of Specific gravity urine decreased.

On Jul, 08, 2026

22,833 people reported to have side effects when taking Oxybutynin.
Among them, 18 people (0.08%) have Specific gravity urine decreased.

Could Oxybutynin cause Specific gravity urine decreased?

Among these 18 people:

How long have people been on Oxybutynin when they have Specific gravity urine decreased? *

What is the gender of people who have Specific gravity urine decreased when taking Oxybutynin? *

female: 94.12 %
male: 5.88 %

What is the age of people who have Specific gravity urine decreased when taking Oxybutynin? *

What are other drugs people take besides Oxybutynin? *

What are other side effects people have besides Specific gravity urine decreased? *

White Blood Cells Urine Positive: 17 people, 94.44%
Feeling Abnormal: 17 people, 94.44%
Monocyte Percentage Increased: 17 people, 94.44%
White Blood Cell Count Decreased: 17 people, 94.44%
Lymphocyte Percentage Decreased: 17 people, 94.44%
Lymphocyte Count Decreased: 17 people, 94.44%
Klebsiella Test Positive: 17 people, 94.44%
Itching: 17 people, 94.44%
Insomnia (sleeplessness): 17 people, 94.44%
Headache (pain in head): 17 people, 94.44%

What are the existing conditions these people have? *

Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 17 people, 94.44%
Sleep Disorder: 13 people, 72.22%
Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Oxybutynin and have Specific gravity urine decreased?

- Check whether Specific gravity urine decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Oxybutynin:

Oxybutynin (23,143 reports)

Browse all side effects of Oxybutynin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Specific gravity urine decreased:

Specific gravity urine decreased (66 drugs)

Browse all the conditions that are associated with Specific gravity urine decreased:

Specific gravity urine decreased (78 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on oxybutynin (the active ingredients of Oxybutynin) and Oxybutynin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.